W.H.W. Inman

4.1k total citations · 2 hit papers
60 papers, 2.6k citations indexed

About

W.H.W. Inman is a scholar working on Psychiatry and Mental health, Toxicology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, W.H.W. Inman has authored 60 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 9 papers in Toxicology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in W.H.W. Inman's work include Pharmacovigilance and Adverse Drug Reactions (9 papers), Reproductive Health and Contraception (6 papers) and Epilepsy research and treatment (6 papers). W.H.W. Inman is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (9 papers), Reproductive Health and Contraception (6 papers) and Epilepsy research and treatment (6 papers). W.H.W. Inman collaborates with scholars based in United Kingdom, United States and Canada. W.H.W. Inman's co-authors include M P Vessey, A M Adelstein, J I Mann, Martin Vessey, B Westerholm, G. L. Pearce, W. W. Mushin, Nigel S. B. Rawson, Gillian Pearce and Lynda Wilton and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

W.H.W. Inman

60 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

1970 465 citations W.H.W. Inman et al. BMJ profile →
Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.

1968 322 citations W.H.W. Inman et al. BMJ profile →

Peers

W.H.W. Inman

PHEOH

CCM

PPCH

EDM

PRM

B Westerholm Sweden

Diane K. Wysowski United States

Laura E. Derby United States

William J. Stone United States

M Fainaru Israel

Judith K. Jones United States

Petter Urdal Norway

Dennis Slone United States

Rita Schinnar United States

S. Shapiro United States

B Westerholm Sweden

W.H.W. Inman

700 ×1.0

PHEOH

454 ×1.2

CCM

335 ×1.1

PPCH

419 ×1.4

EDM

316 ×1.1

PRM

Citations per year, relative to W.H.W. Inman W.H.W. Inman (= 1×) peers B Westerholm

Countries citing papers authored by W.H.W. Inman

Since Specialization

Citations

This map shows the geographic impact of W.H.W. Inman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.H.W. Inman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.H.W. Inman more than expected).

Fields of papers citing papers by W.H.W. Inman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.H.W. Inman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.H.W. Inman. The network helps show where W.H.W. Inman may publish in the future.

Co-authorship network of co-authors of W.H.W. Inman

This figure shows the co-authorship network connecting the top 25 collaborators of W.H.W. Inman. A scholar is included among the top collaborators of W.H.W. Inman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.H.W. Inman. W.H.W. Inman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Kubota, Kiyoshi, Naozumi Kubota, G. L. Pearce, & W.H.W. Inman. (1996). ACE-inhibitor-induced cough, an adverse drug reaction unrecognised for several years: studies in Prescription-Event Monitoring. European Journal of Clinical Pharmacology. 49(6). 431–437. 16 indexed citations

2.

Prescott, P., et al.. (1996). TESTING FOR ADVERSE REACTIONS USING PRESCRIPTION EVENT MONITORING. Statistics in Medicine. 15(10). 987–1002. 9 indexed citations

3.

Inman, W.H.W., G. L. Pearce, & Lynda Wilton. (1994). Safety of fluconazole in the treatment of vaginal candidiasis. European Journal of Clinical Pharmacology. 46(2). 115–8. 49 indexed citations

4.

Edwards, Jeffrey G., W.H.W. Inman, Lynda Wilton, & Gillian Pearce. (1994). Prescription-Event Monitoring of 10401 Patients Treated with Fluvoxamine. The British Journal of Psychiatry. 164(3). 387–395. 36 indexed citations

5.

Edwards, J. Guy, W.H.W. Inman, Gillian Pearce, & Nigel S. B. Rawson. (1991). Prescription-Event Monitoring of 10 895 Patients Treated with Alprazolam. The British Journal of Psychiatry. 158(3). 387–392. 15 indexed citations

6.

Rawson, Nigel S. B., Gillian Pearce, & W.H.W. Inman. (1990). Prescription-event monitoring: Methodology and recent progress. Journal of Clinical Epidemiology. 43(5). 509–522. 36 indexed citations

7.

Speirs, C., C. T. Dollery, W.H.W. Inman, Nigel S. B. Rawson, & L. V. Wilton. (1988). Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure.. BMJ. 297(6652). 830–832. 33 indexed citations

8.

Inman, W.H.W., Nigel S. B. Rawson, L. V. Wilton, G. L. Pearce, & C. Speirs. (1988). Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.. BMJ. 297(6652). 826–829. 83 indexed citations

9.

Inman, W.H.W., et al.. (1985). Peptic ulcer and piroxicam. BMJ. 290(6482). 1663.4–1664. 1 indexed citations

10.

Inman, W.H.W.. (1984). Prescription‐Event Monitoring. Acta Medica Scandinavica. 215(S683). 119–126. 8 indexed citations

11.

Inman, W.H.W. & Nigel S. B. Rawson. (1983). Erythromycin estolate and jaundice.. BMJ. 286(6382). 1954–1955. 23 indexed citations

12.

Inman, W.H.W.. (1982). Prescription-event monitoring.. BMJ. 285(6344). 809.3–810. 8 indexed citations

13.

Inman, W.H.W.. (1979). Oral contraceptives and fatal subarachnoid haemorrhage.. BMJ. 2(6203). 1468–1470. 48 indexed citations

14.

Inman, W.H.W., et al.. (1977). Drug monitoring : proceedings of an international workshop held in Honolulu from 24 to 28 January, 1977 and sponsored by CIBA-GEIGY. Academic Press eBooks. 2 indexed citations

15.

Inman, W.H.W., et al.. (1977). Maternal drug histories and congenital abnormalities.. BMJ. 2(6091). 853–856. 86 indexed citations

16.

Mann, J I, W.H.W. Inman, & Margaret Thorogood. (1976). Oral contraceptive use in older women and fatal myocardial infarction.. BMJ. 2(6033). 445–447. 78 indexed citations

17.

Inman, W.H.W. & W. W. Mushin. (1974). Jaundice after Repeated Exposure to Halothane: An Analysis of Reports to the Committee on Safety of Medicines. BMJ. 1(5896). 5–10. 132 indexed citations

18.

Inman, W.H.W. & David A. Evans. (1972). Evaluation of Spontaneous Reports of Adverse Reactions to Drugs. BMJ. 3(5829). 746–749. 9 indexed citations

19.

Inman, W.H.W.. (1970). Monitoring of adverse reactions to drugs in the United Kingdom.. PubMed. 63(12). 1302–4. 5 indexed citations

20.

Inman, W.H.W.. (1968). INCREASE OF THROMBO‐EMBOLIC DISEASE AND THE PILL. BJOG An International Journal of Obstetrics & Gynaecology. 75(12). 1315–1315. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact